US$ 24.66
blue cross blue shield glp 1 coverage 2025 to stop covering popular weight-loss drugs BCBSM pulling back on GLP-1
Description
P.HathawayD

Endocrinology (1996) 137(9):367480.10.1210/endo.137.9.8756532 51 LamariYBoissardCMoukhtarMSJullienneARosselinGGarelJM

The investments weve made on our platform will help ensure that we can effectively help the millions of potential Americans that can benefit from our holistic approach to weight loss treatment

In our experience, the rate at which patients are willing and able to stay on treatment depends less on the medication itself than on how their clinical team responds to symptoms

A quick dose adjustment or lab check often resolves the issue within weeks

Supplementary Information The online version contains supplementary material available at 10.1007/s13300-025-01722-x
